Athersys (FRA:4LSA) Beginning Cash Position : €1.69 Mil (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Athersys Beginning Cash Position?

Athersys's Beginning Cash Position for the quarter that ended in Sep. 2023 was €1.69 Mil.

Athersys's quarterly Beginning Cash Position declined from Mar. 2023 (€8.44 Mil) to Jun. 2023 (€2.88 Mil) and declined from Jun. 2023 (€2.88 Mil) to Sep. 2023 (€1.69 Mil).

Athersys's annual Beginning Cash Position increased from Dec. 2020 (€28.80 Mil) to Dec. 2021 (€45.62 Mil) but then declined from Dec. 2021 (€45.62 Mil) to Dec. 2022 (€35.31 Mil).

Athersys Beginning Cash Position Historical Data

The historical data trend for Athersys's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athersys Beginning Cash Position Chart

Athersys Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Beginning Cash Position

Get a 7-Day Free Trial

25.77

45.95

28.80

45.62

35.31

Athersys Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Beginning Cash Position	Get a 7-Day Free Trial															13.51	13.01	8.44	2.88	1.69

Athersys Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Athersys Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Athersys's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Athersys (FRA:4LSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Athersys Inc (FRA:4LSA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ATHXQ:USA

Address

3201 Carnegie Avenue, Cleveland, OH, USA, 44115-2634

Website

https://www.athersys.com

Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Athersys (FRA:4LSA) Headlines

No Headlines